e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Biomarkers and other new methods for lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COPD as an independent risk factor for lung cancer in patients with bronchial squamous dysplasia
A. Mohamed, K. Shibuya, I. Yoshino, T. Mahfouz, A. Abdrabou, M. Elkholy (Assuit, Egypt; Chiba, Japan)
Source:
Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Session:
Biomarkers and other new methods for lung cancer
Session type:
Thematic Poster Session
Number:
2785
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Mohamed, K. Shibuya, I. Yoshino, T. Mahfouz, A. Abdrabou, M. Elkholy (Assuit, Egypt; Chiba, Japan). COPD as an independent risk factor for lung cancer in patients with bronchial squamous dysplasia. Eur Respir J 2011; 38: Suppl. 55, 2785
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
COPD is a risk factor for squamous cell histotype in smokers who develop nonsmall cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 361s
Year: 2003
Systemic inflamation and bronchial dysplasia in risk lung cancer subjects
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
Chronic obstructive pulmonary disease is an independent risk factor for nonsmall cell lung cancer in smokers
Source: Eur Respir J 2002; 20: Suppl. 38, 254s
Year: 2002
Bronchial bacterial colonization in patients with resectable lung carcinoma
Source: Eur Respir J 2002; 19: 326-332
Year: 2002
Coexistence of COPD in lung cancer patients
Source: Eur Respir J 2001; 18: Suppl. 33, 66s
Year: 2001
Earlier stages, higher incidence of squamous and lower incidence of small cell and adenocarcinomas among lung cancer patients with coexisting COPD
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009
Incidence of lung cancer among COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 494s
Year: 2005
Pecularities of lung cancer in patients with COPD
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011
Procalitonin: A prognosis factor in lung cancer and a marker for small-cell lung cancer
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011
Angiogenesis in bronchial biopsies of symptomatic smokers with and without lung cancer
Source: Annual Congress 2008 - Basic science in asthma and COPD II
Year: 2008
Bilateral lung cancer with COPD or metastatic disease
Source: International Congress 2016 – CC4 Major challenges in thoracic surgical oncology
Year: 2016
Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009
COPD prevalence in lung cancer patients – Is COPD a risk factor for lung cancer?
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011
Clinicopathologic features of patients with non-small cell lung cancer and chronic obstructive pulmonary disease undergoing lung cancer surgery
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Year: 2020
Management of concomitant COPD in patients with lung cancer
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018
COPD in patients with lung cancer and smoking
Source: Eur Respir J 2005; 26: Suppl. 49, 519s
Year: 2005
How to treat lung cancer in IPF patients
Source: Research Seminar 2015
Year: 2015
COPD, asthma, and lung cancer patients
Source: International Congress 2016 – ME13 Smoking cessation in difficult population groups
Year: 2016
Risk factors for lung cancer in COPD
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
COPD and lung cancer incidence in never smokers
Source: International Congress 2019 – Asthma and COPD comorbidities
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept